
Advancing Precision Health and Research Using Ultra-sensitive Blood Biomarker Detection
33 Gerrard Street West, Toronto, Ontario, M5G 1Z4, Canada
Join us for an immersive exploration of the applications of Simoa® technology, including patient stratification and compound efficacy, in areas such as neurology, neuroimmunology, and women’s health.
Download flyer for more details.
This session is part of the Quanterix Simoa® Roadshow Series
Agenda:
| Time | Topic | Speaker |
|---|---|---|
| 11:30 AM | Arrival and lunch | |
| 12:00 PM | Welcome |
Jim Maki Sr. BDM, Quanterix |
| 12:05 PM | Simoa® overview and new assays (brain derived tau, pTau-217, and more) |
Sam Olson, PhD FAS, Quanterix |
| 12:20 PM | Patient-centered design of biomarker-based diagnostics: towards equitable women’s healthcare |
Alana Ogata, PhD Assistant Professor |
| 12:35 PM | Using Simoa® in neurodegenerative diseases and possible Chronic Traumatic Encephalopathy |
Carmela Tartaglia, MD, FRCPC |
| 12:50 PM | Application of Neurological Biomarkers - the Canadian Military Experience |
Shawn Rhind, PhD Sr. Defense Scientist – Defense Research and Development Canada (DRDC) |
| 1:05 PM | Q&A and User Discussion | |
|
1:30 PM |
Depart |